Navigation Links
Dr. Inder Verma named recipient of 2008 Vilcek Prize in biomedical science
Date:2/6/2008

New York, February 6, 2008 - The Vilcek Foundation has announced the names of the recipients of its annual prizes in biomedical research and in the arts. Dr. Inder Verma is the prize recipient for biomedical science; the prize recipient for the arts is composer Osvaldo Golijov. The Vilcek Foundation Prizes are awarded annually to foreign-born individuals for extraordinary contributions to society in the United States.

In explaining the motivation for the awards, Dr. Jan T. Vilcek, President of The Vilcek Foundation said, We should not have to be reminded of how much America owes to people who were born abroad, but we do. Historically, the United States has innumerable foreign-born individuals to thank for establishing it as a leader in the sciences and arts, and in many other fields as well. In awarding The Vilcek Foundation Prizes, our primary objective is to raise awareness of that reality. We should not forget that so much of what this country takes credit for is the achievement of immigrants.

Marica Vilcek, Vice-President of the Foundation, added: As the only foundation to recognize the outstanding contributions of foreign-born individuals to the biomedical sciences and the arts, we are in a privileged position to shine a spotlight on leaders such as Dr. Verma and Mr. Golijov, whose achievements we are pleased to honor this year.

A $50,000 cash award and a commemorative trophy created by designer Stefan Sagmeister will be presented to Dr. Verma and Mr. Golijov during The Foundations third annual awards dinner on Wednesday, March 26, 2008 at the Mandarin Oriental Hotel in New York. The two prize winners were chosen by independent panels of experts.

About the Prize Recipient

Dr. Inder M. Verma is an American Cancer Society Professor of Molecular Biology in the Laboratory of Genetics at The Salk Institute in La Jolla, California and one of the world's leading authorities on the development and use of engineered viruses for gene therapy. Dr. Verma was born in India, received a master's degree from Lucknow University, and a Ph.D. from The Weizmann Institute of Science in Rehovoth, Israel. After postdoctoral study at MIT in the laboratory of the Nobel laureate David Baltimore, he joined the faculty of The Salk Institute at age 26.

Dr. Vermas major research interests are cellular genes whose alteration can cause cancer and the development of techniques for gene therapy. Dr. Vermas group created a vector, or carrier, that is now used worldwide for gene delivery. The genetically engineered virus is used to insert new genes into cells in a test tube; the cells can then be returned to the body, where they produce an essential protein that the body is missing. Dr. Verma's group is also studying two genes implicated in familial breast cancer, BRCA1 and BRCA2, and recently demonstrated that their action is linked to the cell's division cycle and that BRCA1 regulates gene activity.

When the field of biotechnology was in its infancy, the Government of India invited Dr. Verma to join a task force charged with the goal to position the country as a leader in biotechnology. Dr. Verma has traveled to India every year for the past 37 years; he has lectured there on the topic of gene therapy, visited many institutions and advised a number of colleagues, young investigators and students.

For his many outstanding accomplishments, Dr. Verma was elected to the U.S. National Academy of Sciences and as a Foreign Fellow to the National Academy of Sciences, India. Dr. Verma was also elected to the Third World Academy of Sciences, the Institute of Medicine, the American Academy of Arts and Sciences, and the American Philosophical Society.


'/>"/>

Contact: Sharu Williams
sharu.williams@vilcek.org
917-432-5328
The Vilcek Foundation
Source:Eurekalert

Related medicine news :

1. A Reminder to Parents: Early Dental Visits Essential to Childrens Health
2. Independence Blue Cross Delivers Important Reminder to Women during Cervical Cancer Awareness Month
3. Reminder: Exelixis Announces December 10 Webcast of Its Analyst and Investor Briefing in Conjunction with The American Society Of Hematology 48th Annual Meeting
4. Asthma Foundation Offers National Flu Shot Finder
5. Health Insurance Finders Debuts A Comprehensive Guide to Family Health Insurance
6. FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia
7. Genzyme Statement Regarding Results of FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
8. Smilebox and Lifetime Television Promote Breast Cancer Awareness With Multimedia Designs for Sending Mammogram Reminders and Celebrating Courage
9. PartsSource Awarded US Patent for PartsFinder(TM) Application
10. Research says doctors gender may hinder early diagnosis of heart disease in women
11. HealthInsuranceFinders.com Launches Video Contest for Young Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important ... problem. Fortunately, an inventor from Austin, Texas, has identified a solution. , She developed ... darkness or restricted lighting. As such, it eliminates the need to turn on a ...
(Date:10/13/2017)... ... October 13, 2017 , ... Southern ... and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice Frueh, ... cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU School ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills ... specialty vendors and unique items from across the nation, this holiday-themed event will raise ... offered by the VNA. The boutique will be open Saturday, November 4 (10:00 ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob Lowe, ... in a new episode of "Success Files," which is an award-winning educational program ... investigates each subject in-depth with passion and integrity. , Sciatica occurs when the ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... ZirMed Inc ., a recognized leader in cloud-based revenue cycle ... ranked #1 by its users for the seventh consecutive year ... ZirMed was recognized as the top-ranked end-to-end revenue cycle management ... 200 beds and holds one of the longest #1 ranking ... ...
(Date:9/12/2017)... -- Consumer reviews on the independent review site Consumer Affairs ... for hearing aids, ranking it higher than Miracle Ear ™, ... ... Hearing Aids ... store that provides high performance, state-of-the-art, German-engineered hearing aids directly to ...
Breaking Medicine Technology: